Wendell Wierenga serves as Executive at Dermata Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Wendell Wierenga has executed 9 insider transactions totaling $1.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 22, 2025 involved exercising options for 20,000 shares valued at $152.2K.
Wendell Wierenga currently holds 52,444 shares of Dermata Therapeutics, Inc. (DRMA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Wendell Wierenga has been a net seller of DRMA stock. They have purchased $0 and sold $1.6M worth of shares.
Wendell Wierenga's most recent insider trade was on Dec 22, 2025, when they sold 20,000 shares at $7.61 per share.
Get notified when new Form 4 filings are submitted
| $66.14 |
| Discretionary |
| Oct 27, 2025 | CYTK | $43.8K | Option Exercise | 4,375 | $10.00 | Discretionary |
| Oct 27, 2025 | CYTK | $256.7K | Sale | 4,375 | $58.68 | Discretionary |
| Oct 15, 2025 | CYTK | $6.2K | Award | 99 | $62.80 | Discretionary |
| Oct 6, 2022 | DRMA | $0 | Award | 20,654 | $N/A | Discretionary |
| Jul 7, 2022 | DRMA | $0 | Award | 18,110 | $N/A | Discretionary |
| Apr 7, 2022 | DRMA | $0 | Award | 10,593 | $N/A | Discretionary |
| Aug 17, 2021 | DRMA | $0 | Conversion | 8,163 | $N/A | Discretionary |